Alkermes
ALKS
#3153
Rank
NZ$7.98 B
Marketcap
NZ$47.91
Share price
0.43%
Change (1 day)
-17.73%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): NZ$0.70 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.52 Billion. In 2024 the company made an earning of NZ$0.80 Billion a decrease over its 2023 earnings that were of NZ$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.70 B-12.98%
2024 NZ$0.80 B-17.97%
2023 NZ$0.98 B-468.52%
2022 -NZ$0.27 Billion449.24%
2021 -NZ$48.48 Million-68.04%
2020 -NZ$0.16 Billion-52.1%
2019 -NZ$0.32 Billion64.49%
2018 -NZ$0.2 Billion-15.04%
2017 -NZ$0.23 Billion-34.2%
2016 -NZ$0.35 Billion-5.34%
2015 -NZ$0.37 Billion35084.97%
2014 -NZ$1.04 Million
2012 NZ$12.81 M-117.81%
2011 -NZ$71.94 Million-12.69%
2010 -NZ$82.4 Million94.3%
2009 -NZ$42.41 Million-117.7%
2008 NZ$0.23 B622.63%
2007 NZ$33.15 M
2004 -NZ$0.14 Billion-14.48%
2003 -NZ$0.16 Billion11.88%
2002 -NZ$0.14 Billion39.65%
2001 -NZ$98.14 Million5.73%
2000 -NZ$92.82 Million-28.91%
1999 -NZ$0.14 Billion237.28%
1998 -NZ$38.71 Million100.05%
1997 -NZ$19.35 Million-37.93%
1996 -NZ$31.17 Million82.72%
1995 -NZ$17.06 Million-26.79%
1994 -NZ$23.3 Million-72.78%
1993 -NZ$85.61 Million208.07%
1992 -NZ$27.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.91 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.22 B 3,931.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$20.45 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.70 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$13.86 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.59 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.37 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.47 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.71 B 430.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel